Recent technical advances and indications for radiation therapy in low-grade glioma

Seminars in Radiation Oncology

Volumn 25, Issue 3, 2015, Pages 189-196

  Chan, Michael D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; GLIOMA; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEREOTACTIC RADIOSURGERY; TREATMENT INDICATION; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR VOLUME; BRAIN NEOPLASMS; CONFORMAL RADIOTHERAPY; PROCEDURES; RADIOTHERAPY DOSAGE;

BRAIN NEOPLASMS; GLIOMA; HUMANS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84943160893     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2015.02.001     Document Type: Review

References (43)

1. van den Bent MJ, Afra D, de Witte O, et al: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 366:985-990, 2005
2. Pignatti F, van den Bent M, Curran D, et al: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076-2084, 2002
3. Shaw EG, Berkey B, Coons SW, et al: Recurrence following neurosurgeondetermined gross-total resection of adult supratentorial low-grade glioma: Results of a prospective clinical trial. J Neurosurg 109:835-841, 2008
4. Shaw EG, Wang M, Coons SW, et al: Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: Initial results of RTOG 9802. J Clin Oncol 30:3065-3070, 2012
5. Buckner JC, Pugh SL, Shaw EG, et al: Phase III study of radiation therapy with or without PCV in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG. J Clin Oncol 32:2014, [abstr 2000].
6. Fisher BJ, Lui J, Macdonald DR, et al: A phase II study of a temozolomidebased chemoradiotherapy regimen for high-risk low-grade gliomas: Preliminary results of RTOG 0424. J Clin Oncol 31 2013. [abstr 2008]
7. Ginsberg LE, Fuller GN, Hashmi M, et al: The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: Histopathological evaluation of a series. Surg Neurol 49:436-440, 1998
8. Kreth FW, Faist M, Rossner R, et al: Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors. Cancer 79:370-379, 1997
9. Shaw E, Arusell R, Scheithauer B, et al: Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial lowgrade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20:2267-2276, 2002
10. Saito T, Yamasaki F, Kajiwara Y, et al: Role of perfusion-weighted imaging at 3 T in the histopathological differentiation between astrocytic and oligodendroglial tumors. Eur J Radiol 81:1863-1869, 2012
11. Karim AB, Maat B, Hatlevoll R, et al: A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36:549-556, 1996
12. Peiffer AM, Leyrer CM, Greene-Schloesser DM, et al: Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology 80:747-753, 2013
13. Kelly PJ, Daumas-Duport C, Kispert DB, et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987
14. Kracht LW, Miletic H, Busch S, et al: Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: Local comparison with stereotactic histopathology. Clin Cancer Res 10:7163-7170, 2004
15. Paulsson AK, McMullen KP, Peiffer AM, et al: Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol 37:177-181, 2014
16. Paulino AC, Mazloom A, Terashima K, et al: Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer 119:2654-2659, 2013
17. Roberge D, Souhami L, Olivier A, et al: Hypofractionated stereotactic radiotherapy for low grade glioma at McGill University: Long-term followup. Technol Cancer Res Treat 5:1-8, 2006
18. Tanaka S, Shin M, Mukasa A, et al: Stereotactic radiosurgery for intracranial gliomas. Neurosurg Clin N Am 24:605-612, 2013
19. Kano H, Kondziolka D, Niranjan A, et al: Stereotactic radiosurgery for pilocytic astrocytomas part 1: Outcomes in adult patients. J Neurooncol 95:211-218, 2009
20. Park KJ, Kano H, Kondziolka D, et al: Early or delayed radiosurgery for WHO grade II astrocytomas. J Neurooncol 103:523-532, 2011
21. Merchant TE, Kiehna EN, Li C, et al: Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys 63:1546-1554, 2005
22. Merchant TE, Conklin HM, Wu S, et al: Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 27:3691-3697, 2009
23. Kano H, Niranjan A, Kondziolka D, et al: Stereotactic radiosurgery for pilocytic astrocytomas part 2: Outcomes in pediatric patients. J Neurooncol 95:219-229, 2009
24. Hukin J, Siffert J, Velasquez L, et al: Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors. Neuro Oncol 4:253-260, 2002
25. Zhang R, Howell RM, Homann K, et al: Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy. Radiat Oncol 8:184, 2013
26. Newhauser WD, Fontenot JD, Mahajan A, et al: The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 54:2277-2291, 2009
27. Hauswald H, Rieken S, Ecker S, et al: First experiences in treatment of lowgrade glioma grade I and II with proton therapy. Radiat Oncol 7:189, 2012
28. van den Bent MJ, Wefel JS, Schiff D, et al: Response assessment in neurooncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583-593, 2011
29. Ducray F, Kaloshi G, Houillier C, et al: Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy. J Neurooncol 115:261-265, 2013
30. McMullen KP, Papagikos MA, Glazier SS, et al: Pseudo-progression based on MRI changes following radiation therapy for pilocytic astrocytoma. Int J Radiat Oncol Biol Phys 66:S243-S244, 2006
31. Meyzer C, Dhermain F, Ducreux D, et al: A case report of pseudoprogression followed by complete remission after proton-beam irradiation for a low-grade glioma in a teenager: The value of dynamic contrast-enhanced MRI. Radiat Oncol 5:9, 2010
32. Lin AL, Liu J, Evans J, et al: Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol 16:123-130, 2014
33. Geer CP, Simonds J, Anvery A, et al: Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study. Am J Neuroradiol 33:556-562, 2012
34. Soffietti R, Chio A, Giordana MT, et al: Prognostic factors in welldifferentiated cerebral astrocytomas in the adult. Neurosurgery 24:686-692, 1989
35. Danchaivijitr N, Waldman AD, Tozer DJ, et al: Low-grade gliomas: Do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 247:170-178, 2008
36. Forsyth PA, Kelly PJ, Cascino TL, et al: Radiation necrosis or glioma recurrence: Is computer-assisted stereotactic biopsy useful? J Neurosurg 82:436-444, 1995
37. Leighton C, Fisher B, Bauman G, et al: Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation. J Clin Oncol 15:1294-1301, 1997
38. Kaloshi G, Sierra del Rio M, Ducray F, et al: Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide. J Neurooncol 100:439-441, 2010
39. Cuneo KC, Vredenburgh JJ, Desjardins A, et al: Impact of concurrent and adjuvant bevacizumab on the risk of radiation necrosis following radiosurgery for recurrent glioma. Int J Radiat Oncol Biol Phys 84:S7, 2012
40. Hallemeier CL, Pollock BE, Schomberg PJ, et al: Stereotactic radiosurgery for recurrent or unresectable pilocytic astrocytoma. Int J Radiat Oncol Biol Phys 83:107-112, 2012
41. Kano H, Niranjan A, Khan A, et al: Does radiosurgery have a role in the management of oligodendrogliomas? J Neurosurg 110:564-571, 2009
42. Fogh S, Glass C, Carry B, et al: Hypofractionated stereotactic radiotherapy as salvage therapy for recurrent low-grade glioma. Cancer Ther 7:423-428, 2009
43. Combs SE, Ahmadi R, Schulz-Ertner D, et al: Recurrent low-grade gliomas: The role of fractionated stereotactic re-irradiation. J Neurooncol 71:319-323, 2005